From Medscape Rheumatology

Spondyloarthritis Research and Treatment Network (SPARTAN) Annual Meeting 2023

May 19 - 20, 2023; Cleveland, Ohio, and Virtual

May 19 - 20, 2023 Cleveland, Ohio, and Virtual

Meta-Analysis Probes Cancer Risk Concern for JAK Inhibitors Although no increased cancer risk was seen vs methotrexate or placebo, Janus kinase inhibitors were associated with a higher cancer risk than were tumor necrosis factor inhibitors in a meta-analysis.
Medscape Medical News, Apr 26, 2023
Researchers Seek to Understand Post-COVID Autoimmune Risk Three large studies link past SARS-CoV-2 infection to new-onset autoimmune disease, but it is not yet clear what drives this relationship.
Medscape Medical News, May 01, 2023
NSAIDs May Mask MRI Findings in Spondyloarthritis Cases Among nearly 1 in 4 patients whose MRI results were initially positive for sacroiliitis, results were negative 6 weeks after NSAIDs were taken.
Medscape Medical News, Apr 28, 2023

Disclaimer

Credit:
500px / Getty Images

Medscape Rheumatology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Related Coverage

Related Resources